Clinical trial
Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00064324 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00064324 |
|---|---|
| Title | Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma |
| Official title | A Phase II Study of Perifosine in Soft Tissue Sarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma |
| Intervention type | Drug, Other |
| Interventions | perifosine, laboratory biomarker analysis, pharmacological study |
| Enrollment | 46 |
| Start date | Jun 1, 2003 |
| Primary completion | Nov 1, 2005 |
| First posted | Jul 9, 2003 |
| Last update posted | Jun 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: